title: Intravenous interferon-alpha treatment of mixed cryoglobulinemia associated with chronic hepatitis C virus infection.
authors.forename: V
authors.initials: V
authors.lastname: Zeller
authors.forename: P
authors.initials: P
authors.lastname: Cohen
authors.forename: Q T
authors.initials: QT
authors.lastname: Nguyen
authors.forename: P
authors.initials: P
authors.lastname: Lebon
authors.forename: S
authors.initials: S
authors.lastname: Dziri
authors.forename: F
authors.initials: F
authors.lastname: Ferrière
authors.forename: P
authors.initials: P
authors.lastname: Dény
authors.forename: L
authors.initials: L
authors.lastname: Guillevin
mesh_terms: D000368:Aged; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003449:Cryoglobulinemia / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007275:Injections, Intravenous; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012367:RNA, Viral / Q000097:blood; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012367:RNA, Viral; D011241:Prednisone